Arizona Republic reports MindCrowd goal of 1 million participants
Monday, June 24, 2013
This article in the Arizona Republic explains Dr. Huentelman's
vision for MindCrowd and how scientists are going to use the test
results to help find a cure for Alzheimer's.
"Before we can discover new treatments for brain-related
diseases such as Alzheimer's and Parkinson's, we need to understand
the human genetic blueprint - DNA - that determines how the brain
works in healthy individuals," he (Huentelman) said. "Then, we will
be better equipped to develop new medicines and therapies for
individuals with brain disorders."
Read the article here.